Ticker > Company >

DCM Shriram FineChem share price

DCM Shriram Fine Chemicals Ltd.

NSE: DSFCL BSE: 544703 SECTOR: Chemicals  8.12 K   0   0

23.80
+0.39 (1.67%)
BSE: 10 Jul 04:01 PM

Price Summary

Today's High

₹ 24.15

Today's Low

₹ 23.03

52 Week High

₹ 52.49

52 Week Low

₹ 17.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

207.04 Cr.

Enterprise Value

193.76 Cr.

No. of Shares

8.7 Cr.

P/E

0

P/B

1.03

Face Value

₹ 2

Div. Yield

1.68 %

Book Value (TTM)

₹  23.03

CASH

21.11 Cr.

DEBT

7.83 Cr.

Promoter Holding

50.11 %

EPS (TTM)

₹  -0.49

Sales Growth

-10.21%

ROE

-2.22 %

ROCE

-1.27%

Profit Growth

-123.3 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-10.21%
3 YearNA
5 YearNA

Profit Growth

1 Year-123.3%
3 YearNA
5 YearNA

ROE%

1 Year-2.22%

ROCE %

1 Year-1.27%

Debt/Equity

0.0391

Price to Cash Flow

12.69

Interest Cover Ratio

-1.8441

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 50.11 0.00
Dec 2025 50.11 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 32.5532 days.
  • Company has a healthy liquidity position with current ratio of 2.5338.
  • The company has a high promoter holding of 50.11%.
  • Promoter stake has increased from 0% to 50.11% in the last 1 quarter.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of 0% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 33.2981.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2025 Mar 2026
Net Sales 96.95 93.08
Total Expenditure 96.63 95.58
Operating Profit 0.32 -2.5
Other Income 0.64 0.43
Interest 0.24 0.69
Depreciation 2.11 2.06
Exceptional Items 0 0
Profit Before Tax -1.39 -4.82
Tax 0.23 -0.74
Profit After Tax -1.62 -4.08
Adjusted EPS (Rs) -0.19 -0.47

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2025 Mar 2026
Net Sales 429.37 385.55
Total Expenditure 396.48 381.89
Operating Profit 32.89 3.66
Other Income 2.84 2.16
Interest 2.06 1.45
Depreciation 8.8 8.5
Exceptional Items 0 0
Profit Before Tax 24.88 -4.14
Tax 6.41 0.16
Net Profit 18.46 -4.3
Adjusted EPS (Rs.) 0 -0.49

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 0 17.4
Total Reserves 205.07 182.97
Borrowings 2.71 0
Other N/C liabilities 15.87 17.13
Current liabilities 74.74 67.22
Total Liabilities 298.39 284.72
Assets
Net Block 130.86 103.27
Capital WIP 0.02 0.23
Intangible WIP 0 0
Investments 4.47 4.47
Loans & Advances 4.55 6.03
Other N/C Assets 0.06 0.39
Current Assets 158.42 170.32
Total Assets 298.39 284.72
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2025 Mar 2026
Profit from operations 24.88 -4.14
Adjustment 8.98 11.5
Changes in Assets & Liabilities -9.88 13.19
Tax Paid -9.29 -4.24
Operating Cash Flow 14.69 16.31
Investing Cash Flow 0.2 10.47
Financing Cash Flow -14.84 -5.86
Net Cash Flow 0.05 20.92

Corporate Actions

Investors Details

PARTICULARS Dec 2025% Mar 2026%
promoters 50.11 50.11
aditi dhar 1.46 1.76
akshay dhar 1.46 1.76
akshay foundation 3.42 3.42
alok bansidhar shriram 2.75 10.28
lala bansi dhar & sons 13.83 13.83
madhav bansidhar shriram 4.94 10.28
suman bansi dhar 2.02 2.02
urvashi tilak dhar 6.77 6.77
divya shriram 4.19 -
kanika shriram 1.67 -
karuna shriram 4.76 -
rohan shriram 0.04 -
rudra shriram 1.10 -
tilak dhar & sons 0.58 -
uday shriram 1.11 -
PARTICULARS Dec 2025% Mar 2026%
investors 49.89 49.89
abakkus emerging opportun... - 2.86
dcm shriram fine chemical... - 1.24
investor education and pr... 3.39 3.39
life insurance corporatio... 4.64 4.64
abakkus emerging opportun... 2.86 -
dcm shriram international... 1.24 -
hb portfolio limited 3.85 -

Annual Reports

Title Link
Title Link
Annual Report 2026

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

DCM Shriram FineChem Stock Price Analysis and Quick Research Report. Is DCM Shriram FineChem an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse DCM Shriram FineChem. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). DCM Shriram FineChem has a PE ratio of -48.2507583417594 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. DCM Shriram FineChem has ROA of -1.4756% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. DCM Shriram FineChem has a Current ratio of 2.5338.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. DCM Shriram FineChem has a ROE of -2.2174%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. DCM Shriram FineChem has a Debt to Equity ratio of 0.0391 which means that the company has low proportion of debt in its capital.

  • Sales growth: DCM Shriram FineChem has reported revenue growth of -10.2059% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of DCM Shriram FineChem for the current financial year is 0.949317430885239%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for DCM Shriram FineChem is Rs 0.4 and the yield is 1.6688%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of DCM Shriram FineChem is Rs -0.4945. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of DCM Shriram FineChem in Ticker for free. Also, one can get the intrinsic value of DCM Shriram FineChem by using Valuation Calculators, which are available with a Finology ONE subscription. 

DCM Shriram FineChem FAQs

Q1. What is DCM Shriram FineChem share price today?
Ans: The current share price of DCM Shriram FineChem is Rs 23.86.

Q2. What is the market capitalisation of DCM Shriram FineChem?
Ans: DCM Shriram FineChem has a market capitalisation of Rs 207.56335341 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of DCM Shriram FineChem?
Ans: The PE ratio of DCM Shriram FineChem is -48.2507583417594 and the P/B ratio of DCM Shriram FineChem is 1.03590950336258, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of DCM Shriram FineChem share?
Ans: The 52-week high share price of DCM Shriram FineChem is Rs 52.5, and the 52-week low share price of DCM Shriram FineChem is Rs 17.28.

Q5. Does DCM Shriram FineChem pay dividends?
Ans: Currently, DCM Shriram FineChem pays dividends. Dividend yield of DCM Shriram FineChem is around 1.6688%.

Q6. What are the face value and book value of DCM Shriram FineChem shares?
Ans: The face value of DCM Shriram FineChem shares is Rs 2, while the book value per share of DCM Shriram FineChem is around Rs 23.0329. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of DCM Shriram FineChem?
Ans: DCM Shriram FineChem has a total debt of Rs 7.8306 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of DCM Shriram FineChem?
Ans: The ROE of DCM Shriram FineChem is -2.2174% and ROCE of DCM Shriram FineChem is -1.2657%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is DCM Shriram FineChem a good buy for the long term?
Ans: The DCM Shriram FineChem long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is DCM Shriram FineChem undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the DCM Shriram FineChem appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check DCM Shriram FineChem’s financials?
Ans: You can review DCM Shriram FineChem’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about DCM Shriram FineChem
X